SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

CUNEO, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 24.226
EU - Europa 7.036
AS - Asia 5.593
SA - Sud America 127
AF - Africa 14
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 13
Totale 37.023
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 24.148
CN - Cina 2.657
UA - Ucraina 1.656
DE - Germania 1.503
SG - Singapore 1.301
IT - Italia 1.206
TR - Turchia 1.171
GB - Regno Unito 700
FI - Finlandia 510
SE - Svezia 400
PL - Polonia 362
FR - Francia 232
ID - Indonesia 193
RU - Federazione Russa 138
VN - Vietnam 134
BR - Brasile 115
BE - Belgio 89
CA - Canada 68
CZ - Repubblica Ceca 68
NL - Olanda 58
HK - Hong Kong 42
IN - India 34
LT - Lituania 29
AT - Austria 27
ES - Italia 12
IR - Iran 12
AU - Australia 11
JP - Giappone 11
EU - Europa 10
IE - Irlanda 10
RO - Romania 9
CH - Svizzera 6
IL - Israele 6
KR - Corea 6
MX - Messico 6
MA - Marocco 5
UZ - Uzbekistan 5
HU - Ungheria 4
PE - Perù 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
BD - Bangladesh 3
BY - Bielorussia 3
MK - Macedonia 3
NZ - Nuova Zelanda 3
PK - Pakistan 3
BG - Bulgaria 2
CL - Cile 2
DZ - Algeria 2
EC - Ecuador 2
HR - Croazia 2
NG - Nigeria 2
PA - Panama 2
PH - Filippine 2
RS - Serbia 2
TN - Tunisia 2
TW - Taiwan 2
BH - Bahrain 1
BO - Bolivia 1
CO - Colombia 1
EE - Estonia 1
EG - Egitto 1
GT - Guatemala 1
JM - Giamaica 1
JO - Giordania 1
LU - Lussemburgo 1
MY - Malesia 1
NO - Norvegia 1
OM - Oman 1
PT - Portogallo 1
SA - Arabia Saudita 1
SI - Slovenia 1
SN - Senegal 1
UY - Uruguay 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 37.023
Salva come PNG Salva come JPEG
Città #
Fairfield 3.015
Woodbridge 2.968
Houston 1.998
Jacksonville 1.857
Chandler 1.676
Ann Arbor 1.362
Ashburn 1.333
Santa Clara 1.290
Seattle 1.157
Wilmington 1.125
Singapore 1.006
Cambridge 976
Izmir 644
Nanjing 592
Beijing 567
Princeton 480
Warsaw 354
San Diego 311
Boardman 307
Ferrara 273
New York 225
Milan 210
Shanghai 204
Jakarta 189
Shenyang 188
Nanchang 172
Helsinki 136
Dong Ket 132
Munich 129
Hebei 128
Bremen 115
Addison 113
Los Angeles 98
Changsha 97
Tianjin 93
Falls Church 88
Jiaxing 87
Brussels 86
Dearborn 83
London 73
Jinan 71
Mountain View 69
Redwood City 63
Zhengzhou 63
Norwalk 55
Brno 47
Kunming 46
San Mateo 46
Toronto 42
Hong Kong 40
Ningbo 40
Falkenstein 38
Guangzhou 37
Frankfurt am Main 35
Bologna 34
Orange 34
Des Moines 28
Washington 28
Auburn Hills 27
Rome 27
Lappeenranta 25
Taizhou 25
Tappahannock 25
Verona 24
Augusta 22
Chicago 22
Hangzhou 21
Indiana 21
Nuremberg 21
Ottawa 21
Changchun 20
Olomouc 19
Florence 18
Lanzhou 18
Philadelphia 18
Haikou 17
Leawood 16
Parma 16
San Francisco 16
Redmond 15
Napoli 14
Hefei 13
San Jose 13
Fidenza 12
Vienna 12
Kilburn 11
Lozzo Atestino 11
Council Bluffs 10
Naples 10
Prineville 10
Springfield 10
Bari 9
Amsterdam 8
Fuzhou 8
Monmouth Junction 8
Newark 8
Dublin 7
Hounslow 7
Modena 7
Mumbai 7
Totale 27.402
Salva come PNG Salva come JPEG
Nome #
A His-155 to Tyr polymorphism confers gain-of-function to the human P2X7 receptor of human leukemic lymphocytes. 249
Aberrant expression of HLA-DR antigen by bone marrow-derived mesenchymal stromal cells from patients affected by acute lymphoproliferative disorders 204
In CLL, comorbidities and the complex karyotype are associated with an inferior outcome independently of CLL-IPI 193
Individual quality assessment of autografting by probability estimation for clinical endpoints: a prospective validation study from the European group for blood and marrow transplantation 192
CXCR4 pos circulating progenitor cells coexpressing monocytic and endothelial markers correlating with fibrotic clinical features are present in the peripheral blood of patients affected by systemic sclerosis 183
The anti-leukemic activity of sodium dichloroacetate in p53(mutated/null) cells is mediated by a p53-independent ILF3/p21 pathway 181
Prognostic impact of genetic characterization in the GIMEMA LAM99P multicenter study for newly diagnosed acute myeloid leukemia. 179
Sodium dichloroacetate exhibits anti-leukemic activity in B-chronic lymphocytic leukemia (B-CLL) and synergizes with the p53 activator Nutlin-3 172
Involvement of the P2X7-NLRP3 axis in leukemic cell proliferation and death 168
Diagnostic work-up for clinical and prognostic assessment of acute leukaemia 166
The active metabolite of warfarin (3′-hydroxywarfarin) and correlation with INR, warfarin and drug weekly dosage in patients under oral anticoagulant therapy: A pharmacogenetics study 166
Ibrutinib synergizes with MDM-2 inhibitors in promoting cytotoxicity in B chronic lymphocytic leukemia 161
13q14 deletions in chronic lymphoproliferative disorders with the t(11;14)(q13;q32): a cytogenetic and interphase cytogenetic study. 160
13q14 deletion in non-Hodgkin's lymphoma: Correlation with clinicopathologic features 159
MORFOLOGIA E FISIOPATOLOGIA DEL SANGUE E DEGLI ORGANI EMOPOIETICI 154
P2X7 receptor expression in evolutive and indolent forms of chronic B lymphocytic leukemia 150
The p53 transcriptional pathway is preserved in ATMmutated and NOTCH1mutated chronic lymphocytic leukemias 149
Preferential expression of the transcription coactivator HTIF1alpha gene in acute myeloid leukemia and MDS-related AML 149
5' region and exon 7 mutations of the TP53 gene in two cases of B-cell prolymphocytic leukemia. 148
Thrombosis of the cerebral veins and sinuses in acute promyelocytic leukemia after all-trans retinoic acid treatment: a case report. 147
Clonal evolution including 14q32/IGH translocations in chronic lymphocytic leukemia: analysis of clinicobiologic correlations in 105 patients 147
Acquired chromosome 11q deletion involving the ataxia teleangiectasia locus in B-cell non-Hodgkin's lymphoma: Correlation with clinicobiologic features 146
A functional role for soluble HLA-G antigens in immune modulation mediated by mesenchymal stromal cells 146
Novel small deletions of the p53 gene in late stage B-cell chronic lymphocytic leukaemia 145
A highly sensitive and specific fluorescence in situ hybridization (FISH) approach for the detection of t(9;11)(p22-23;q23) in acute myeloid leukemia. 145
Acute Human Herpesvirus-6A infection of human mesothelial cells modulates HLA molecules 145
Incidence and significance of cryptic chromosome aberrations detected by fluorescence in situ hybridization in acute myeloid leukemia with normal karyotype 143
A novel t(9;11)(p22;q23) with ALL-1 gene rearrangement associated with progression of a myeloproliferative disorder to acute myeloid leukemia 142
Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: Clinical and biological correlations 140
A comprehensive genetic classification of adult acute lymphoblastic leukemia (ALL): analysis of the GIMEMA 0496 protocol 139
Soluble urokinase-type Plasminogen Activator Receptor (suPAR) as an independent factor predicting worse prognosis and extra bone marrow involvement in multiple myeloma patients 139
Employment of Oligodeoxynucleotide plus Interleukin-2 Improves Cytogenetic Analysis in SplenicMarginal Zone Lymphoma 139
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients 138
A decreased positivity for CD90 on human mesenchymal stromal cells (MSCs) is associated with a loss of immunosuppressive activity by MSCs 137
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations. 137
Identifying High-Risk Chronic Lymphocytic Leukemia: A Pathogenesis-Oriented Appraisal of Prognostic and Predictive Factors in Patients Treated with Chemotherapy with or without Immunotherapy 137
In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristics 136
Secondary chromosome changes in mantle cell lymphoma: cytogenetic and fluorescence in situ hybridization studies. 135
CYTOGENETIC ABERRATIONS IN THE CD38 POSITIVE FRACTION OF CD38 NEGATIVE CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS: A MARKER OF AGGRESSIVENESS? 134
Tryptase-positive mast cells predict clinical outcome of patients with early B-cell chronic lymphocytic leukemia 134
Factor XIII-A dynamics in acute myocardial infarction: a novel prognostic biomarker? 134
Chromosome aberrations in atypical chronic lymphocytic leukemia: a cytogenetic and interphase cytogenetic study 133
Minimal morphological criteria for defining bone marrow dysplasia: A basis for clinical implementation of WHO classification of myelodysplastic syndromes 133
Ibrutinib in the real world patient: Many lights and some shades 133
Clinical importance of interphase cytogenetics detecting occult chromosome lesions in myelodysplastic syndromes with normal karyotype 133
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 132
Exposure to myelotoxic agents and myelodysplasia: case-control study and correlation with clinicobiological findings. 132
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 131
In Vitro Characterization of Circulating Endothelial Progenitor Cells Isolated from Patients with Acute Coronary Syndrome 130
Waldenstrom macroglobulinemia 130
Endothelium-mediated survival of leukemic cells and angiogenesis-related factors are affected by lenalidomide treatment in chronic lymphocytic leukemia. 128
BCR/ABL1-positive acute lymphoblastic leukemia relapsing as BCR/ABL1-negative acute lymphoblastic leukemia 128
Chronic lymphocytic leukemia with 6q- shows distinct hematological features and intermediate prognosis 126
Fluorescence in situ hybridization for the detection and monitoring of the Ph-positive clone in chronic myelogenous leukemia: Comparison with metaphase banding analysis 125
Functional integrity of the p53-mediated apoptotic pathway induced by the nongenotoxic agent nutlin-3 in B-cell chronic lymphocytic leukemia (B-CLL) 125
null 124
Long-term outcome of chronic myeloid leukemia patients treated frontline with imatinib 124
Exercise training and endothelial progenitor cells in haemodialysis patients 124
REFINED KARYOTYPE-BASED PROGNOSTIC STRATIFICATION OF CHRONIC LYMPHOCYTIC LEUKEMIA WITH A VERY LOW RISK GENETIC PROFILE 124
Delirium in acute promyelocytic leukemia patients: two case reports. 124
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations 124
A novel translocation t(1;7)(p36;q34) in three patients with acute myeloid leukaemia 123
A novel recurrent translocation t(11;14)(p11;q32) in splenic marginal zone B cell lymphoma 122
Dendritic cells in acute promyelocytic leukaemia 121
Hsa-miR-15a and Hsa-miR-16-1 expression is not related to proliferation centers abundance and other prognostic factors in chronic lymphocytic leukemia 121
Interleukin-3 plus interleukin-6 may improve chromosomal analysis of multiple myeloma: Cytologic and cytogenetic evidence in thirty-four patients 120
Neoplastic circulating endothelial-like cells in patients with acute myeloid leukaemia. 119
Differentiating chronic lymphocytic leukemia from monoclonal B-lymphocytosis according to clinical outcome on behalf of the GIMEMA chronic lymphoproliferative diseases working group 119
In patients with myelodysplastic syndromes response to rHuEPO and G-CSF treatment is related to an increase of cytogenetically normal CD34+ cells. 118
Erratum to: Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlations (J Hematol Oncol. (2016) 9 (88) DOI:10.1186/s13045-016-0320-z) 118
null 118
Hepatosplenic T-cell lymphoma (HSTCL). 117
Cytogenetic and clinicobiological features of acute leukemia with stem cell phenotype: study of nine cases 117
MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia 117
[Use of 5-phosphodiesterase inhibitors in patients with LUTS secondary to BPH: our experience and review of the literature]. 117
Richter's syndrome in a case of atypical chronic lymphocytic leukaemia with the t(11;14)(q13;q32): role for a p53 exon 7 gene mutation 116
Chromosome 14q32 translocations involving the immunoglobulin heavy chain locus in chronic lymphocytic leukaemia identify a disease subset with poor prognosis. 116
A prospective survey of febrile events in hematological malignancies 115
Myelofibrosis with Myeloid Metaplasia (MMM)/Idiopathic myelofibrosis/Agnogenic myeloid metaplasia 115
A highly sensitive and specific fluorescence in situ hybridization (FISH) approach for the detection of t(9;11)(p22-23;q23) in acute myeloid leukemia. 114
Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia 114
CLINICAL AND BIOLOGICAL CHARACTERIZATION OF CIRCULATING ENDOTHELIAL CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA 113
Proliferation centers in chronic lymphocytic leukemia: correlation with cytogenetic and clinicobiological features in consecutive patients analyzed on tissue microarrays 113
Etiology of Febrile Episodes in Patients With Acute Myeloid Leukemia: Results From the Hema e-Chart Registry 113
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN A PATIENT WITH RELAPSED CHRONIC LYMPHOCYTIC LEUKEMIA TREATED WITH IBRUTINIB 113
Distinct cytogenetic and clinicopathologic features in acute myeloid leukemia after occupational exposure to pesticides and organic solvents. 113
Minor myeloid component in Ph chromosome-positive acute lymphoblastic leukaemia: correlation with cytogenetic pattern and implication for poor response to therapy 112
Adult T-cell acute lymphoblastic leukemia: biologic profile at presentation and correlation with response to induction treatment in patients enrolled in the GIMEMA LAL 0496 protocol 112
An Italian retrospective study on the routine clinical use of low-dose alemtuzumab in relapsed/refractory chronic lymphocytic leukaemia patients 112
Dendritic cell recovery after allogeneic stem-cell transplantation in acute leukemia: correlations with clinical and transplant characteristics. 112
Trisomy 8 in PDGFRB-negative cells in a patient with imatinib-sensitive chronic myelomonocytic leukemia and t(5;16)(q33;p13) PDGFRB-NDE1 fusion 111
t(4;11)(q21;p15) translocation involving NUP98 and RAP1GDS1 genes: characterization of a new subset of T acute lymphoblastic leukaemia 111
B-Cell chronic lymphocytic leukemia (B-CLL) with 14q32 translocations: haematological features and clinical outcome. 110
Special cytological subtypes of acute myeloid leukaemias and myelodysplastic syndromes 110
Biological significance and prognostic/predictive impact of complex karyotype in chronic lymphocytic leukemia 110
Therapy-related adult acute lymphoblastic leukemia with t(4;11)(q21;q23): MLL rearrangement, p53 mutation and multilineage involvement 110
Early CP CML, Nilotinib 400 mg Twice Daily Frontline: Beyond 3 Years, Results Remain Excellent and Stable (A GIMEMA CML Working Party Trial) 110
Neoplastic circulating endothelial cells in multiple myeloma with 13q14 deletion 109
Differentiation of follicular dendritic sarcoma cells into functional myeloid-dendritic cell-like elements. 109
“Hemophagocytic Lymphohistiocytosis after EBV reactivation and ibrutinib treatment in relapsed/refractory Chronic Lymphocytic Leukemia” 109
Totale 13.400
Salva come PNG Salva come JPEG
Categoria #
all - tutte 201.451
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 23.600
Totale 225.051
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.597 0 0 0 0 0 0 0 748 574 810 333 132
2020/20215.638 418 469 311 546 275 620 206 639 109 802 779 464
2021/20224.235 230 531 203 195 226 230 230 260 138 359 427 1.206
2022/20234.073 500 178 138 464 698 594 181 363 560 21 250 126
2023/20242.042 186 284 97 50 128 283 89 111 65 55 79 615
2024/20253.957 315 200 787 324 1.145 746 242 198 0 0 0 0
Totale 37.740